In a report published Thursday, Deutsche Bank analyst Darren Lehrich reiterated a Buy rating on Brookdale Senior Living BKD, but lowered the price target from $36.00 to $35.00.
In the report, Deutsche Bank noted, “We are updating model to incorporate some considerations for 2014: the net effect of the update brings CFFO/sh estimate down $0.24 to $2.65, which is now more in-line w/consensus, and still reflects solid +10% YoY growth. We continue to believe BKD will see YoY gains in occupancy and rate growth, so the key changes in our model relate to: (1) slightly higher health benefit costs due to ACA; (2) slightly higher G&A assumptions; (3) lower assumed in-organic growth due to slower M&A environment, and (4) slightly lower EF contributions. Maintain Buy, although trimming PT to $35 ($36) based on 11.5x modestly lower out-yr 2015 CFFO/sh of $3.03 ($3.22).”
Brookdale Senior Living closed on Wednesday at $28.46.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in